Evidence map›Paper›PMID 32801677›Full record

SynthesisInternational journal of chronic obstructive pulmonary disease2020

Thoracic Imaging at Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review.

Bojidar A Rangelov, Alexandra L Young, Joseph Jacob, Anthony P Cahn, Sarah Lee, Frederick J Wilson, David J Hawkes, John R Hurst

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in International journal of chronic obstructive pulmonary disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Quantitative computed tomography and predictive modelling for COPD exacerbations.European respiratory review : an official journal of the European Respiratory Society · 2025
    Pooled it
  2. An Inhaled PI3Kδ Inhibitor Improves Recovery in Acutely Exacerbating COPD Patients: A Randomized Trial.International journal of chronic obstructive pulmonary disease · 2021
    Trial
  3. Observational
  4. Article
  5. Article
  6. Article
  7. TRPV4 Inhibition Exerts Protective Effects Against Resistive Breathing Induced Lung Injury.International journal of chronic obstructive pulmonary disease
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Bojidar A RangelovCentre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, University College London, London, UK.ORCID 0000-0001-7017-1575
Alexandra L YoungCentre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, University College London, London, UK.
Joseph JacobCentre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, University College London, London, UK.
Anthony P CahnGlaxoSmithKline Research and Development, Stevenage, UK.
Sarah LeeAmallis Consulting LTD, London, UK.ORCID 0000-0002-4130-1892
Frederick J WilsonGlaxoSmithKline Research and Development, Stevenage, UK.ORCID 0000-0002-5572-6058
David J HawkesCentre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, University College London, London, UK.ORCID 0000-0001-7151-1762
John R HurstUCL Respiratory, University College London, London, UK.
University College London · GBGlaxoSmithKline (United Kingdom) · GBKing's College London · GB

Funding

Medical Research Council MR/T027800/1
6 · The paper itself

Abstract

Exacerbations of chronic obstructive pulmonary disease (COPD) are currently diagnosed based on changes in respiratory symptoms. Characterizing the imaging manifestation of exacerbations could be useful for objective diagnosis of exacerbations in the clinic and clinical trials, as well as provide a mechanism for monitoring exacerbation treatment and recovery. In this systematic review, we employed a comprehensive search across three databases (Medline, EMBASE, Web of Science) to identify studies that performed imaging of the thorax at COPD exacerbation. We included 51 from a total of 5,047 articles which met all our inclusion criteria. We used an adapted version of the Modified Newcastle-Ottawa Quality Assessment Scale for cohort studies to assess the quality of the included studies. Conclusions were weighted towards higher-quality articles. We identified a total of 36 thoracic imaging features studied at exacerbation of COPD. Studies were generally heterogeneous in their measurements and focus. Nevertheless, considering studies which performed consecutive imaging at stable state and exacerbation, which scored highest for quality, we identified salient imaging biomarkers of exacerbations. An exacerbation is characterized by airway wall and airway calibre changes, hyperinflation, pulmonary vasoconstriction and imaging features suggestive of pulmonary arterial hypertension. Most information was gained from CT studies. We present the first ever composite imaging signature of COPD exacerbations. While imaging during an exacerbation is comparatively new and not comprehensively studied, it may uncover important insights into the acute pathophysiologic changes in the cardiorespiratory system during exacerbations of COPD, providing objective confirmation of events and a biomarker of recovery and treatment response.

Indexed as

Pulmonary Disease, Chronic ObstructiveDisease ProgressionHumansCOPDemphysemaradiology and other imaging

Identifiers

PMID32801677
PMCPMC7385406
OpenAlexW3041980199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.